You are using an outdated browser. Please upgrade your browser to improve your experience.

icotinib

Icotinib is a new epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that developed and used in China for the treatment of patients with non-small cell lung cancer (NSCLC).
Target Activities